Lung Fibrosis in Plutonium Workers
-
1999/12/22
-
-
Series: Grant Final Reports
Details
-
Personal Author:
-
Description:There have been few systematic studies of the non-malignant health effects of a-radiation in humans. Animal studies and a recent report from the former Soviet Union suggest an association between plutonium exposure and the development of fibrotic lung disease. Prompted by a case of lung fibrosis in a retired plutonium worker in the United States, we sought to explore whether plutonium inhalation increases the risk for developing chest radiograph abnormalities consistent with pulmonary fibrosis. We conducted a retrospective study of nuclear weapons workers. To date, our study population consists of327 plutonium-exposed workers with absorbed lung doses from 0 to 2,800 rem and 194 workers who had no estimated plutonium exposure. Participants were predominantly male (97.6%) with a mean age of 63.8 years. There were no significant differences in time working at the plant, hire year, or smoking habits between the two groups, although plutonium workers were older at the time of chest x-ray (67.4 years vs. 57.7 years). Absorbed lung dose was calculated as part of an internal dose assessment. We compared severity of posteroanterior chest radiograph interstitial abnormalities between the two groups using the International Labour Organization (ILO) profusion scoring system. There was a significantly higher proportion of abnormal chest radiographs among plutonium workers (17.4%) as compared to non-plutonium workers (7.2%), p = <0.01. Plutonium workers were older at time of x-ray than were unexposed workers. However, the proportion of plutonium workers with abnormal chest x-rays remained significantly higher when we restricted analyses to those individuals older than 60 years. Of those plutonium workers with absorbed lung doses greater than 500 rem, 29% had an abnormal chest x-ray compared to other plutonium workers (16%), p = 0.06. Thus, inhaled plutonium may cause lung fibrosis in humans at absorbed lung doses above 500 rem. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Series:
-
Publisher:
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:1-19
-
NIOSHTIC Number:nn:20023539
-
NTIS Accession Number:PB2004-100303
-
Citation:Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, R01-CCR-811855, 1999 Dec; :1-19
-
CAS Registry Number:
-
Federal Fiscal Year:2000
-
Performing Organization:Division of Environmental and Occupational Health Sciences, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206
-
Peer Reviewed:False
-
Start Date:19950930
-
Source Full Name:National Institute for Occupational Safety and Health
-
End Date:19990929
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a8d796d0bdd486a1c3fb81ff37cce133dcefc24c421cd068c6bad1c5fde5e4b75608b33099b4ccd578075a24e44d3d378a528035158e829310bbbc5c100de4da
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like